Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Wally who wrote (2842)	1/22/1998 1:47:00 AM
From: Timothy Grimes	Read Replies (2) \| Respond to of 3906

I really feel bad for you folks who are buying into this HVSF bullshit. I lost a bundle on a scam that mirrors this one almost perfectly in 1997, all the way down to the cutsy names of the people involved and the so called evil shorters controlling the upside potential. I don't want a flame war 'cause I really feel bad for all of you honest folks getting sucked into this pipe dream. Just ask yourself a couple of obvious things: 1. If this product is so great and has so much potential, why is the stock selling for $.50 or so. While valuations do occur, effecient market theory is real and corrections happen almost immediately, based on public information. Are you really smarter than the market? 2. What is up with this dramatic drop in the last few days --ON NO NEWS? 3. Do you really believe "management" infused $10 Million into it? Or doesn't it look like a great headline instead? Why management? Surely there are plenty of venture capitalists available to support the efforts of a legit product...I know, I work for a company that has been getting money for years of support from a multi-billionaire. 4. When the NASDAQ stiffens up the rules for BB stocks what will happen to this one? 5. Clinical trials take years and a ton of money and people. Does this company have an adequate staff and funds to accomplish this? Just some thoughts, please no flames. Tim

To: Wally who wrote (2842)	1/22/1998 10:19:00 AM
From: Tomas	Read Replies (1) \| Respond to of 3906

Wally remember one thing, for all practical purposes the drug that Harvard wants to use has already been FDA approved. What they are bringing to the table that is new is the manner in which it is administered and the encapsulation. Hopefully, and this seems to be the bet most folks are riding on, the Phase II and Phase III testing should move along a little faster, given the previous information generated about the drug. I do agree that $10M is pretty small potatoes for financing any company, let alone a bio-firm. Harvard does have access to there "Parent" company and its facilities, with Dr. See having a vested interest in both. Soooo, maybe its a go and maybe not. Tom